Hype for Phase 1 Alzheimer Study More Impressive Than Results
Last week, the NYT, WSJ, and Wall Street reacted enthusiastically, if not irrationally, to results of a phase 1B (yes, phase 1B) study of another anti-amyloid MAb (yes,...
Read More
-
About Pathophilia
Faux Crystal Blue Persuasion on the Market
From The Onion‘s “TV Club” (no joke). Blue meth, made (er) popular by TV’s “Breaking Bad,” is on the rise. But the blue coloring of...
Read More
Coming Soon: Elixir–The American Tragedy of a Deadly Drug
After more than 10 years of research, I am happy (relieved) to announce my soon-to-be published nonfiction book Elixir: The American Tragedy of a Deadly Drug. Look for...
Read MoreMany Early 20th Century US Medical Journals May Be in Public Domain
For those of us interested in writing about medical history, particularly early 20th-century medical history, a specific hurdle is encountered when attempting to quote,...
Read MoreMany Physicians Regret Career Choice
According to Medscape’s newly published (2012) report on physician income, almost half (46%) of the surveyed physicians (N > 25,000) would not choose medicine as...
Read MoreHollywood Showed Interest in Elixir Sulfanilamide Story
In late October 1937, gossip columnist Louella Parsons revealed that both Warner Brothers and film executive B. P. Schulberg were in preproduction stages for 2 separate...
Read More